tb guidelinesa
-
Upload
desiring0007 -
Category
Documents
-
view
212 -
download
0
Transcript of tb guidelinesa
![Page 1: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/1.jpg)
Diagnosis Of Tuberculosis
![Page 2: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/2.jpg)
A major challenge of childhood TB is establishing an accurate diagnosis.
Less than 15% of cases are sputum acid-fast bacillismear positive, Mycobacterial culture yields are 30%–40%
Cruz AT, Starke JR. Clinical manifestations of TB in children. Pediatr Respir Rev 2007; 8:107–117.
Eamranond P, Jaramaillo E. Tuberculosis in children: reassessing the need for improved diagnosis in global control strategies. Int J Tuberc Lung Dis 2001; 5:594–603.
![Page 3: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/3.jpg)
In non endemic countries, TB is diagnosed based on a triad of
(1) close contact with an infectious index patient,
(2) a positive tuberculin skin test (TST) result
(3) presence of suggestive abnormalities on a chest radiograph.
.
![Page 4: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/4.jpg)
These criteria, however, have limited application in countries where TB is endemic, because– Case detection and contact tracing activities are not routine in national TB programs, – Transmission is not restricted to the household, and– Most individuals acquire infection and become TST
positive during childhood and adolescence
Marais BJ, Gie RP, Schaaf HS, Donald PR, Beyers N, Starke J. Childhoodpulmonary tubetculosis—old wisdom and new challenges. Am J RespCrit Care Med 2006; 173:1078–1090. Marais BJ, Pai M. Recent advances in the diagnosis of childhood tuberculosis.Arch Dis Child 2007;
92:446–452
![Page 5: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/5.jpg)
Pulmonary TB suspect • Fever and/or cough >2weeks
– documentation– nature (any type)– evening rise neither specific nor commonly
present• Cough
dry/moist maybe severe recurrent episodes with normal intervening period is less likely to
be TB In suspected EPTB / CLHA cough of any duration
![Page 6: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/6.jpg)
• h/o unexplained weight loss (defined as weightloss of >5%as compared to
highest weight recorded in last 3 months)
• no weight gain in last 3mths
• Recent loss of appetite
![Page 7: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/7.jpg)
• h/o contact with an infectious TB patient(smear positive).
However , in a symptomatic child contact with any form of active TB in last 2yrs may be significant.
![Page 8: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/8.jpg)
Risk of developing disease after infection
• age at exposure- primary infection before 2 years of age frequently progresses to disease
within the first 12 months the risk of disease progression decreases during childhood,is least at 5–10 years of age, and increases again during adolescence
• nutritional and immune status• magnitude of initial infection. • Severe or disseminated disease- young age and HIV infection
are the most important risk factors
Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhoodintra-thoracic tuberculosis: a critical review of literature from the prechemotherapyera. Int J Tuberc Lung Dis 2004; 8:392–402
![Page 9: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/9.jpg)
• Recent history of whooping cough, measles
• Immunocompromised state : HIV , steroid therapy, chemotherapeutic agents
• Persistant lower respiratory tract infection not responding to antibiotics(non flouroquinolones)
• Significant superficial lymphnode should be specifically looked for , as they may often coexist
![Page 10: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/10.jpg)
Clinically suspected Pulmonary TB case
Sputum examination
Sputum smear positive
Sputum smear positive pulmonary TB
Sputum smear negative /sputum not available for examination
Child has:1. already received a complete course of appropriate Antibiotics2. Sick looking3. Severe respiratory distress4. Any other reason for CXR
![Page 11: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/11.jpg)
YES NO
7d course of antibiotics which has no anti TB activity
CXR and TST
CXR s/o TB and TST positive
GL/BAL/IS to look for AFB, MTb rapid culture or Gene expert wherever facilities
are available
Smear positive: treat as smear positive PTB
Smear negative:Treat as smear negative PTB
Either or both negative
![Page 12: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/12.jpg)
Persistant symptoms
CXR normalTST negative
Review diagnosis
CXR nonspecific shadow , TST +/-
Repeat 7d course of antibiotics if not already received
Persistent shadow
GL/IS/BAL
Smear positive t/t as SPPTB
Look for alternative;If no t/t as SNPTB
CXR normalTST positive
Review for alternate diagnosis
If NO,Look for extrapulmonary siteSeek expert help, CECT chest+/-
![Page 13: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/13.jpg)
Sputum smear negativeSmear-negative tuberculosis is currently defined as • symptomatic illness in a patient • with at least two sputum smear
examinations negative for AFB on different occasions• in whom pulmonary tuberculosis is later
confirmed by culture, biopsy, or other investigations
![Page 14: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/14.jpg)
Extra pulmonary TBEPTB is defined as TB of organs other than the lungsDiagnosis is based on • culture-positive specimen from the extrapulmonary site• histological evidence or• strong clinical evidence consistent with active EPTB disease
followed by a medical officer’s decision to treat with a full course of anti-TB therapy.
Patients suspected of having EPTB should also have their sputum examined for AFB if they have chest symptoms, irrespective of the duration of these symptoms.
A patient diagnosed with both pulmonary and EPTB is classified as a case of pulmonary TB.
![Page 15: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/15.jpg)
Among extrapulmonary manifestations,• Lymphadenopathy is the most common (67%) • Central nervous system(13%) • Pleural (6%), • Miliary and/or disseminated(5%)• Skeletal (4%) TB .
Disseminated (miliary) disease and TB meningitis are usually found in very young children (age <3 years) and/or HIV-infected children [9].
![Page 16: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/16.jpg)
TB lymphadenitisLymphnode enlargement >2cm in one or more sites , with without periadenitis, with without evidence of TB elsewhere or presence of cold abscess with or without discharging sinus
a course of antibiotics for two weeks is prescribed
In case of persistence , suspect TB lymphadenitis
FNAC /pus from discharging sinus , is sent for AFB staining
Diagnosis confirmed if aspirate show ZN stain + for AFB or granulomatous changes on histopathologyIf FNAC results are inconclusive ,exclusive biopsy is advisable
Treat as case
![Page 17: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/17.jpg)
• Mantoux test is positive in a significant proportion.• FNAC is usually adequate for accurate diagnosis
and it co-relates well with biopsy in >90% of cases • Histopathology shows caseous necrosis and
epitheloid granuloma.• AFB in FNAC specimen may be positive in 20-70%
of patients• Reactive lymphadenitis due to recurrent URTI or
tonsillitits may mimic TB ,hence ATT should not be started unless diagnosis is confirmed by FNAC or histopathology.
![Page 18: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/18.jpg)
TUBERCULAR MENINGITISHISTORY of long duration of fever (>1week) with vague CNS symptoms such as behavior changes, irritability, drowsiness, headache, vomiting and seizuresin presence of risk factors like age<5y, Koch’s contact, undernutrition, HIV
EXAMINATION global encephalopathy with focal neurological deficit is the hallmark.
STAGES of TBM:1st stage: lasts typically 1-2 weeks characterized by fever, headache irritabilty, drowsiness and malaise, stagnation or loss of milestones
2nd stage: abrupt onset with lethagy, seizures, positive meningeal signs, hypertonia, vomiting, signs of raised ICT, FND, signs of encephalitis such as disorientation, movement disorders or speech impairment.
3rd stage: coma, hemiplegia/paraplegia, hypertension, decerebrate posturingdeterioration of vital signs and eventually death
![Page 19: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/19.jpg)
CSF study:
Cytology- mild pleocytosis ( 10-500cells/cumm) with lymphocytosis predominantlyCSF protein- markedly high (400-5000mg/dl) CSF glucose-mild reduction (<40mg/dl rarely <20) to be interpreted in conjuction with blood sugar
In inconclusive results, CSF should be repeated 48-72hrs after antibiotic therapy and if it shows no improvement in clinical states and CSF results , it may favor TBM
![Page 20: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/20.jpg)
• CSF show AFB positivity in 30% cases and culture positivity in 50-70% cases, provided 5-10 ml CSF sample is obtained
• Rapid MTb culture has has poor sensitivity (16%) though specificity is high (>90%)
• CSF antibody is not recommended in view of poor sensitivity, specificity and predictive value
• CSF ADA levels cutoff of 7and 11IU/L offer supportive evidence but cannot discriminate between TBM and bacterial meningitis
• CSF PCR(using commercial NAAT) –positive PCR is specific though negative PCR does not rule out TBM
![Page 21: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/21.jpg)
MODIFIED AHUJA CRITERIA:
Mandatory features:•Fever lasting for more than 14 days •Abnormal CSF findings – pleocytosis with more than 20 cells and more than 60% lymphocytes , protein >100mg/dl, CSF sugar <60% of blood sugar
Any of 2 following features-•Evidence of extra neural TB (normal CXR in 20-50%)•Positive TST (1TU) >10mm (nonreactiveTST in upto 50%) •Positive family history of exposure to active TB case•Abnormal CT findings(2 or more) exudates in basal cistern or sylivian fissure hydrocephalus infarcts gyral enhancement
![Page 22: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/22.jpg)
Using response to therapy as the gold standard,modified criteria had the sensitivity of 83%, with a specificity of 63%.
Seth R, S.U., Diagnostic criteria for tuberculous meningitis. Indian J Pediatr, 2002. 69(4): p. 299 303‐
![Page 23: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/23.jpg)
A diagnostic approach to asingle, small, contrast enhancing CT lesion(SSECT)
NCC:
• Size 20 mm• Smooth margin,epicentric
nodule• Min./no surrounding
edema• No midline shift• Greywhite junction of the
cortex
• MRI(T2) : bright
Tuberculoma:
• Size >20mm• Lobulated irregular shape,with central nodule(conglomerate)• Marked oedema causing midline shift • Tuberculomas are usually seen in the base of the brain •MRI(T2): hypointense•MRS : lipid peaks
![Page 24: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/24.jpg)
Pleural effusion• Pleural fluid: Gross- straw coloredCytology- several hundred to thousands early
predominance of PMN later lymphocytosisProteins- 2 to 4gm/dlSugar – 20-40 mg/dlADA levels >60 suggestive . Helps to differentiate b/w
viral and non viral effusionAFB is rarely positive and cultures are positive in
<30%
![Page 25: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/25.jpg)
Abdominal TB
• Localised disease-Mesentric lymphadenopathyEnteritisPeritonitis
• Systemic disseminated disease-hepatosplenomegaly
![Page 26: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/26.jpg)
• Sonography : Corroborative evidence of echogenic
thickened mesentry with lymphnodes >15mm in size, dilated matted bowel loops, thickened omentum and ascites
• Paracentesis: exudative ascites with proteins>3gm/dl with
lymphocytosis• Barium follow through :suggestive of intestinal
disease though not confirmatory
![Page 27: tb guidelinesa](https://reader036.fdocuments.us/reader036/viewer/2022070602/577cce3c1a28ab9e788da0a8/html5/thumbnails/27.jpg)
TB in HIVFeatures of PTB Stage of HIV infection
Early Late
Clinical feature Often resembles post primary
Often resembles primary progressive.Disseminated and extra-pulmonary forms are common
Sputum smear Often positive Often negative
CXR Often cavities Often hilar lymphadenopathy with infiltates esp lower lobes
Diagnosis is difficult •TST can be absent•Culture confirmation is difficult•Clinical features mimic other HIV related conditions•Risk of MDR TB